A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

A bronchodilator is a medication that relaxes and opens the airways, or bronchi, in the lungs. A doctor may prescribe them for asthma and other respiratory conditions. Narrowed airways make it ...

Patients with COPD also have a high prevalence of CVD. Bronchodilators prescribed for symptomatic COPD control may also contribute to cardiovascular risk. In accordance with treatment guidelines, most ...

Many persons with a history of smoking tobacco have clinically significant respiratory symptoms despite an absence of airflow obstruction as assessed by spirometry. They are often treated with ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

Please provide your email address to receive an email when new articles are posted on . Spirometry testing in the afternoon vs. morning was linked to a decreased likelihood for bronchodilator ...

Please provide your email address to receive an email when new articles are posted on . Bronchodilator responsiveness over 20% was linked to exacerbations and decreased prebronchodilator FEV 1. More ...

August 16, 2010 — Nebulized hypertonic 3% saline solution without adjunctive bronchodilators has a low rate of adverse events in infants younger than 2 years with bronchiolitis, according to the ...

COPD can be managed with medications like bronchodilators and corticosteroids, which reduce airway inflammation and open airways for easier breathing. Vaccines for the flu, pneumonia, shingles, RSV, ...

Novartis' dual combination bronchodilator Utibron Neohaler inhalation powder for patients with chronic obstructive pulmonary disease (COPD) has received FDA approval. It is not indicated to treat ...